PMID: 41884493

Combined treatment of pegvisomant and cabergoline in a cat with hypersomatotropism: insulin-like growth factor 1 normalization and control of comorbidities.

Miceli Diego D, Rey Amunategui Juan P, Pompili Gustavo A, Más Javier, Pignataro Omar P, Guitelman Mirtha

JFMS open reports · 2026

Vol. 12, Issue 1, pp. 20551169261427069

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.